|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 107, Issue 2 363-371, Copyright © 1994 by Company of Biologists
JOURNAL ARTICLES |
QL Lu, AM Hanby, MA Nasser Hajibagheri, SE Gschmeissner, PJ Lu, J Taylor-Papadimitriou, S Krajewski, JC Reed and NA Wright
Histopathology Unit, Imperial Cancer Research Fund, London, UK.
bcl-2 gene expression confers a survival advantage by preventing cells from entering apoptosis. In contrast to the previously described cytoplasmic localization of Bcl-2 in epithelial cells in vivo, in this study we have demonstrated, in a series of human epithelial cell lines, that Bcl-2 also localizes to mitotic nuclei. Both immunocytochemical and immunoelectron microscopical examinations localize this protein to nuclei and in particular to chromosomes. Nuclear Bcl-2 expression in these cell lines is correlated with the cell cycle. There is relatively strong expression during mitosis, most intense during prophase and metaphase, declining in telophase and then the protein becomes undetectable soon after separation of the two daughter cells. The expression and distribution of Bcl-2 is influenced by treatment with excessive thymidine. These results indicate that Bcl-2 may protect the cells from apoptosis occurring during mitosis and suggest a possible role for the protein in cell immortalization.
This article has been cited by other articles:
![]() |
M. C. Willingham Conditional Epitopes: Is Your Antibody Always Specific? J. Histochem. Cytochem., October 1, 1999; 47(10): 1233 - 1236. [Full Text] |
||||
![]() |
C. A. Schandl, S. Li, G. G. Re, W. Fan, and M. C. Willingham Mitotic Chromosomal Bcl-2: I. Stable Expression Throughout the Cell Cycle and Association with Isolated Chromosomes J. Histochem. Cytochem., February 1, 1999; 47(2): 139 - 150. [Abstract] [Full Text] |
||||
![]() |
C. A. Schandl, S. Li, G. G. Re, W. Fan, and M. C. Willingham Mitotic Chromosomal Bcl-2: II. Localization to Interphase Nuclei J. Histochem. Cytochem., February 1, 1999; 47(2): 151 - 158. [Abstract] [Full Text] |
||||
![]() |
Y.-H. Ling, C. Tornos, and R. Perez-Soler Phosphorylation of Bcl-2 Is a Marker of M Phase Events and Not a Determinant of Apoptosis J. Biol. Chem., July 24, 1998; 273(30): 18984 - 18991. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Narasimhan, L. Yang, B. I. Gerwin, and V. C. Broaddus Resistance of pleural mesothelioma cell lines to apoptosis: relation to expression of Bcl-2 and Bax Am J Physiol Lung Cell Mol Physiol, July 1, 1998; 275(1): L165 - L171. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Atula, R. Grenman, P. Laippala, and S. Syrjanen Cancer of the Tongue in Patients Younger Than 40 Years: A Distinct Entity? Arch Otolaryngol Head Neck Surg, December 1, 1996; 122(12): 1313 - 1319. [Abstract] [PDF] |
||||
![]() |
Y. Furukawa, S. Iwase, J. Kikuchi, Y. Terui, M. Nakamura, H. Yamada, Y. Kano, and M. Matsuda Phosphorylation of Bcl-2 Protein by CDC2 Kinase during G2/M Phases and Its Role in Cell Cycle Regulation J. Biol. Chem., July 7, 2000; 275(28): 21661 - 21667. [Abstract] [Full Text] [PDF] |
||||